Part 1 Dose Escalation of SLC-3010 Monotherapy and in Combination
Primary Objectives:
Secondary Objectives:
Part 2: Dose Expansion of SLC-3010 Monotherapy and in Combination
Patients must meet all the following inclusion criteria to be eligible for enrollment into the study:
Birth control methods unacceptable for this study include the following:
Individuals who meet any of the following exclusion criteria will not be eligible to participate:
Exceptions: (i) Malignancies that were treated curatively and have not recurred within the past 2 years, or (ii) Completely resected basal cell carcinoma and squamous cell carcinoma of the skin, or (iii) Completely resected carcinoma in situ of any type.